4.8 Article

CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification

Journal

IMMUNITY
Volume 13, Issue 1, Pages 47-57

Publisher

CELL PRESS
DOI: 10.1016/S1074-7613(00)00007-8

Keywords

-

Categories

Funding

  1. NCI NIH HHS [CA81776, CA54464] Funding Source: Medline
  2. NHLBI NIH HHS [HL54476] Funding Source: Medline

Ask authors/readers for more resources

CD19 regulates constitutive and antigen receptor-induced signaling thresholds in B lymphocytes through its unique cytoplasmic domain. Herein, we demonstrate a novel molecular mechanism where interactions between CD19 and Lyn amplify basal and antigen receptor-induced Src family kinase activation. Lyn expression was required for CD19 tyrosine phosphorylation in primary B cells. Experiments with purified proteins demonstrated that CD19-Y-513 was Lyn's initial phosphorylation and binding site. This led to processive phosphorylation of CD19-Y-482, which recruited a second Lyn molecule, allowing for transphosphorylation and amplification of Lyn activation. In vivo, CD19 deficiency impaired, and CD19 overexpression enhanced, Lyn kinase activity. Thus, CD19 functions as a specialized adapter protein for the amplification of Src family kinases that is crucial for intrinsic and antigen receptor-induced signal transduction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available